About Cureety

Bridging the Gap in Cancer Care

In oncology, the most critical moments often occur outside clinic walls. Cureety helps care teams extend their clinical and human reach through its precision care platform that combines tailored symptom monitoring, early risk detection, and care coordination tools.

Cureety’s mission is to work hand-in-hand with care teams and to help join up partners in the digital ecosystem, to collectively expand access to precision care while improving daily life for patients, caregivers, and clinicians. We believe that together, we can help contribute to the future of oncology, enabling more proactive, precise, and human-centered care at scale.

The Platform

A Connected Platform for the Oncology Ecosystem

We integrate advanced treatment and patient supervision through intelligent oncology triage.

01

For Healthcare Providers

We maximize care teams impact by providing remote monitoring in a clinically specific and personalized way. By moving from reactive to proactive management, we filter out the alert noise to prioritize what’s critical—optimizing clinical time, protecting your staff from burnout, and reducing preventable downstream events.

02

For Life Sciences & Pharma

We close the real-world evidence gap. Our platform captures the longitudinal, regulatory-grade data, including safety, tolerability, and functional status, essential for improving trial retention, safety monitoring, and post-market surveillance.

03

For Researchers

We provide a granular look at the patient journey through high-fidelity data that reflects the representative patient experience outside of clinical trials. Our data-driven approach unlocks deeper insights into treatment toxicities and quality-of-life outcomes.

04

For Patients & Caregivers

You are never alone. Cureety is your daily partner, monitoring symptoms in real time and providing the expert guidance and connection needed to stay informed and supported every step of the way.

Expertise

Designed with people, engineered by experts, validated by science.

We are a clinically led team of oncology veterans and digital health pioneers. We understand that precision medicine requires precision monitoring. The future of cancer care isn’t just about more data, it’s about therapy-specific clinical intelligence.

Global Scale

Trustedby 220+ cancer centers, and supported over 70,000 patients globally with over 950,000 therapy-specific questionnaires completed with high patient engagement

Clinical Rigor

Built on a validated algorithm with 95.8% sensitivity and 94.4% specificity for critical classifications.

Operational Excellence

We build infrastructure that streamlines complex processes—from automated reimbursement documentation to remote infusion readiness checks—saving both time and lives.

François-Guirec Champoiseau

CEO / Co-founder

Hugo Breitweiller

Chief Product Officer / Co-Founder

Nicolas Bégin

General Manager

Dr. Maya Gutierrez

Chairman of the Scientific Committee

Misha Kaur

Chief Operating Officer

Charles Parnot

Chief Scientific Officer

Guillaume Gaud

Head of Life Sciences

Pascal Ognibene

Chief Technical Officer

Florent Darrault

Chief Marketing Officer

Co-Design

Co-Design is in Our DNA

We believe the most effective clinical tools are built at the intersection of professional expertise and patient lived experience.

Our Scientific Committee

Ensure the clinical rigor of our solution, content and protocols, and fit with realworkflows

Our Patient Committee

Ensures our interface is intuitive and supportive. We capture symptoms using objective, patient-friendly language, which our clinical intelligence layer then automatically grades against CTCAE standards to support precise clinical decisions.

Our Strategic Partners & Advisors

Ensures our platform remains a sustainable, ethical, and scalable solution for global health systems. They navigate the complexities of market access and health policy to transform clinical innovation into a viable, long-term standard of care.

Scientific Committee

Dr. Emeline Colomba

Medical Oncologist

University Hospital Martinique

Dr. Carole Helissey

Oncologist, Head of Clinical Research

Service de Santé des Armées

Dr. Jean-Baptiste Meric

Medical Oncologist

Centre Hospitalier de Bligny

Dr. Thomas Feutren

Radiation Oncologist

Centre de Cancérologie de la Porte Saint Cloud

Dr. Félix Blanc-Durand

Oncologist

Institut Gustave Roussy

Dr. Côme Bommier

Hematologist

Centre de Cancérologie de la Porte Saint Cloud

Dr. Anne Creisson

Oncologist, Head of DICPA

Centre Antoine Lacassagne

Dr. Audrey Faveyrial

Oncologist, Department Head

Centre François Baclesse

Pr. Cindy Neuzillet

Oncologist, Department Head

Paul Brousse AP-HP

Dr. Noémie Studer

Pain Medicine Physician, Director of Supportive Care

Hôpital Foch

Pr. Lise Boussemart

Onco-Dermatology

University Hospital Nantes

Dr. Berengère Gruson

Hematologist

Clinique de l'Europe

Dr. Romain Kokorian

Uro-Oncology

Clinique Mathilde

Dr. Mathieu Boone

Neuro-Oncologist

Regional University Hospital Amiens

Dr. Raphaël Serre

Radiation Oncologist

Hôpital Pitié-Salpêtrière

Dr. Damien Botsen

Medical Oncologist and Head of the Department of Medical Oncology

Institut Godinot

Dr. Guillaume Desiro

Oncologist, Head of PRIMO Unit

Institut de Cancérologie de Lorraine

Dr. Bertrand Mennecier

Thoracic Oncologist

Regional University Hospital Nancy

Dr. Hélène Gardeney

Hematologist

University Hospital Poitiers

Dr. Guillaume Buiret

Medical Coordinator, Clinical Research Unit

CH Valence

Medical Advisors

Dr. Hope S. Rugo

M.D, FASCO

City of Hope

Dr. Philippe Spiess

Oncologist, Chief of Clinical Innovation

Moffitt Cancer Center

Deborah Boyle

Oncology Nurse Consultant & Educator, AOCN

Dr. Vincent Ma

M.D., Assistant Professor

University of Wisconsin-Madison

Dr. Maryam B. Lustberg

Director Breast Center/Chief Breast Oncology M.D., M.P.H., FASCO

Yale School of Medicine

Dr. Roy Beveridge

Consultant and Board Member, Medical Oncologist

Dr. Stéphane Champiat

MD, PhD, Associate Professor in the Department of Investigational Cancer Therapeutics

University of Texas MD Anderson Cancer Center

Dr Julia Lai-Kwon

Medical Oncologist and Health Services Researcher

Peter MacCallum Cancer Centre

Business Advisors

Bertrand Bégin

Venture capitalist

Pleiade Venture

Philippe Capart

Vice President of Business Development

Thermo Fisher Scientific

Tom Smith

Executive Managing Director

HealthTech Advisory Partners

Sebastien Marque

PhD, Cstat CEO co-founder

Horiana

Dr Philippe Souchois

M.D., Medical Director

Vivalto Sante group

Bruno Lempernesse

CEO

MDClone

Trust

Sustainable Care, Ethical Innovation

In oncology, data is more than just numbers, it is a patient’s story. We adhere to the strictest global standards for data protection and ethical AI, maintaining full HIPAA, ISO 13485, and ISO 27001 compliance. Whether supporting a global clinical trial or a local community clinic, we ensure data is handled with the transparency and security that modern medicine demands.

Network

Strategic partners

Judi

Expert Partner

AVBCC

Scientific Association

ACCC

Scientific Association

NCODA

Scientific Association

Careers

Help Us Rewrite the Standard of Care

Are you a digital health innovator or an oncology expert driven by impact? At Cureety, we don’t just work: we solve. If you’re ready to build the future of remote monitoring and make a tangible difference in global cancer care, we want to meet you.

Connect

Let’s Move Oncology Forward. Ready to Collaborate?

Our support team is here to help. Everyone is welcome, including patients, caregivers and patient associations.